Zhenjian Ge
Overview
Explore the profile of Zhenjian Ge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang P, Sun C, Lin S, Lu C, Wen Z, Ge Z, et al.
Clin Chim Acta
. 2025 Jan;
569:120150.
PMID: 39889920
Background: Prostate cancer (PC) is the second most common malignant tumor in males and a leading cause of cancer-related morbidity and mortality among men. Early detection is essential for improving...
2.
Ge Z, Lin S, Lu C, Xia Y, Li R, Li X, et al.
Front Oncol
. 2025 Jan;
14():1470457.
PMID: 39777350
Background: Bladder cancer (BC) is a common tumor worldwide. Screening for BC currently lacks a highly efficient, non-invasive, and inexpensive method. Serum microRNA (miRNA), which is stable and commonly present,...
3.
Chen S, Lu C, Lin S, Sun C, Wen Z, Ge Z, et al.
Front Genet
. 2024 May;
15:1371441.
PMID: 38818039
Prostate cancer (PCa) is one of the most prevalent malignancies affecting the male life cycle. The incidence and mortality of prostate cancer are also increasing every year. Detection of MicroRNA...
4.
He T, Lu C, Gong W, Ge Z, Li R, Li X, et al.
Front Biosci (Landmark Ed)
. 2024 May;
29(5):186.
PMID: 38812297
Background: Clear cell renal cell carcinoma (ccRCC) is a prevalent malignant tumor affecting the urinary system. Due to its unfavorable prognosis, there is a pressing need to discover effective approaches...
5.
Lu C, Lin S, Wen Z, Sun C, Ge Z, Chen W, et al.
Biomarkers
. 2024 May;
29(5):276-284.
PMID: 38767408
Background: Bladder cancer (BC) is one of the ten most common cancers worldwide with late detection and early age of diagnosis. There is abundant evidence that early detection and timely...
6.
Chen W, Wang W, Zhao Z, Wen Z, Li Y, Ge Z, et al.
Front Oncol
. 2024 May;
14:1391844.
PMID: 38720802
Background: Renal cell carcinoma (RCC) stands as the most prevalent form of urogenital cancer. However, there is currently no universally accepted method for predicting the prognosis of RCC. MiRNA holds...
7.
Sun C, Lu C, Li X, Li R, Wen Z, Ge Z, et al.
Transl Cancer Res
. 2024 Mar;
13(2):686-698.
PMID: 38482417
Background: Prostate cancer (PCa) remains a worldwide public health problem that poses a serious threat to the health of men worldwide. Many studies have found that microRNA (miRNA) in serum...
8.
Wen Z, Li Y, Zhao Z, Li R, Li X, Lu C, et al.
Cancer Cell Int
. 2024 Jan;
24(1):18.
PMID: 38191389
Background: Although non-invasive radiological techniques are widely applied in kidney renal clear cell carcinoma (KIRC) diagnosis, more than 50% of KIRCs are detected incidentally during the diagnostic procedures to identify...
9.
Lin S, Sun C, Li R, Lu C, Li X, Wen Z, et al.
Int J Biol Markers
. 2023 Nov;
39(1):70-79.
PMID: 37960876
Background: Globally, prostate cancer is the second most common malignancy in males. Serum microRNAs (miRNAs) may function as non-invasive and innovative biomarkers for various cancers. Our study aimed to determine...